CAPTRUST Financial Advisors
IBB icon

CAPTRUST Financial Advisors’s iShares Biotechnology ETF IBB Stock Holding History

CAPTRUST Financial Advisors’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.27M Buy
13,449
+525
+4% +$89.8K ﹤0.01% 1149
2025
Q4 		$2.18M Sell
12,924
-6,105
-32% -$992K ﹤0.01% 1056
2025
Q3 		$2.75M Buy
19,029
+334
+2% +$45.6K 0.01% 874
2025
Q2 		$2.37M Buy
18,695
+2,614
+16% +$321K 0.01% 903
2025
Q1 		$2.06M Sell
16,081
-36,706
-70% -$4.98M 0.01% 895
2024
Q4 		$6.98M Buy
52,787
+6,301
+14% +$886K 0.02% 461
2024
Q3 		$6.77M Sell
46,486
-1,680
-3% -$243K 0.02% 457
2024
Q2 		$6.61M Sell
48,166
-13,150
-21% -$1.76M 0.02% 441
2024
Q1 		$8.41M Buy
61,316
+8,337
+16% +$1.14M 0.03% 378
2023
Q4 		$7.2M Sell
52,979
-2,399
-4% -$293K 0.02% 445
2023
Q3 		$6.77M Buy
55,378
+1,552
+3% +$197K 0.03% 419
2023
Q2 		$6.83M Sell
53,826
-3,348
-6% -$435K 0.03% 406
2023
Q1 		$7.38M Buy
57,174
+4,468
+8% +$585K 0.03% 357
2022
Q4 		$6.92M Sell
52,706
-3,161
-6% -$409K 0.03% 364
2022
Q3 		$6.53M Sell
55,867
-2,706
-5% -$336K 0.04% 336
2022
Q2 		$6.89M Buy
58,573
+25,884
+79% +$3.07M 0.04% 312
2022
Q1 		$4.26M Buy
32,689
+2,052
+7% +$267K 0.03% 400
2021
Q4 		$4.68M Sell
30,637
-610
-2% -$94.4K 0.03% 377
2021
Q3 		$5.05M Sell
31,247
-215
-0.7% -$36.2K 0.04% 316
2021
Q2 		$5.15M Buy
31,462
+335
+1% +$51.6K 0.05% 292
2021
Q1 		$4.69M Buy
31,127
+19,776
+174% +$3.14M 0.05% 282
2020
Q4 		$1.72M Sell
11,351
-572
-5% -$81.7K 0.02% 444
2020
Q3 		$1.63M Sell
11,923
-781
-6% -$106K 0.03% 381
2020
Q2 		$1.75M Buy
12,704
+154
+1% +$19.6K 0.03% 378
2020
Q1 		$1.3M Sell
12,550
-1,931
-13% -$222K 0.03% 372
2019
Q4 		$1.74M Buy
14,481
+737
+5% +$82.2K 0.03% 398
2019
Q3 		$1.37M Sell
13,744
-252
-2% -$26.4K 0.05% 268
2019
Q2 		$1.53M Buy
13,996
+203
+1% +$21.6K 0.06% 247
2019
Q1 		$1.54M Buy
13,793
+198
+1% +$21.7K 0.06% 220
2018
Q4 		$1.31M Buy
13,595
+165
+1% +$17.5K 0.07% 187
2018
Q3 		$1.64M Sell
13,430
-90
-0.7% -$10.6K 0.07% 168
2018
Q2 		$1.49M Buy
13,520
+633
+5% +$67.7K 0.08% 137
2018
Q1 		$1.32M Sell
12,887
-277
-2% -$30.7K 0.08% 140
2017
Q4 		$1.41M Sell
13,164
-26,652
-67% -$2.85M 0.09% 134
2017
Q3 		$1.43M Buy
39,816
+29,181
+274% +$3.12M 0.11% 82
2017
Q2 		$1.1M Buy
10,635
+426
+4% +$42K 0.14% 42
2017
Q1 		$998K Buy
10,209
+8,850
+651% +$847K 0.1% 42
2016
Q4 		$120K Buy
1,359
+489
+56% +$44.5K 0.01% 91
2016
Q3 		$75K Sell
870
-1,653
-66% -$157K 0.01% 56
2016
Q2 		$216K Sell
2,523
-843
-25% -$75.6K 0.02% 26
2016
Q1 		$293K Sell
3,366
-189
-5% -$16.9K 0.03% 54
2015
Q4 		$401K Buy
3,555
+2,019
+131% +$219K 0.04% 61
2015
Q3 		$155K Sell
1,536
-255
-14% -$30.6K 0.02% 63
2015
Q2 		$220K Sell
1,791
-462
-21% -$55.3K 0.03% 56
2015
Q1 		$258K Buy
2,253
+462
+26% +$51K 0.05% 46
2014
Q4 		$181K Buy
+1,791
New +$174K 0.04% 57
2014
Q3 		– Sell
-1,881
Closed -$161K – 82
2014
Q2 		$161K Sell
1,881
-9,033
-83% -$712K 0.04% 60
2014
Q1 		$860K Buy
10,914
+10,203
+1,435% +$850K 0.18% 37
2013
Q4 		$54K Buy
711
+321
+82% +$22.8K 0.01% 100
2013
Q3 		$27K Hold
390
– – 0.01% 109
2013
Q2 		$23K Buy
+390
New +$22.5K 0.01% 117

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CAPTRUST Financial Advisors's IBB Position: Q1 2026 in Review

CAPTRUST Financial Advisors increased its iShares Biotechnology ETF (IBB) stake by 4.1% in Q1 2026, buying an estimated $89.8K and bringing the position to 13,449 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1149.

CAPTRUST Financial Advisors first reported a position in IBB in Q2 2013 and has held it in 51 quarters since. The position peaked at $8.41M in Q1 2024. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • CAPTRUST Financial Advisors held 13,449 shares of iShares Biotechnology ETF worth $2.27M as of Q1 2026.
  • CAPTRUST Financial Advisors bought 525 iShares Biotechnology ETF shares in Q1 2026, an estimated $89.8K.
  • iShares Biotechnology ETF made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q1 2026, its #1149 holding.
  • CAPTRUST Financial Advisors first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 51 quarters since.
  • CAPTRUST Financial Advisors's iShares Biotechnology ETF position peaked at $8.41M in Q1 2024.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q1 2026, filed 15 May 2026.